A new report suggests that one episode of heparin-induced thrombocytopenia need not rule out the future use of heparin, at least in the context of cardiac procedures. A simple screen for the ...

Heparin-induced thrombocytopenia (HIT) can be a serious complication of unfractionated heparin therapy. There are two types of HIT: Type I HIT: This form is non-immune mediated. Thrombocytopenia ...

Heparin-dependent antibodies are transient; thus, reexposure to heparin is appropriate in patients with a history of heparin-induced thrombocytopenia (and who no longer have detectable platelet ...

Heparin is widely used as an anticoagulant, but evokes in some patients a potentially life-threatening condition called HIT. Clinical scientists at Ludwig-Maximilians-Universitaet (LMU) in Munich ...

The clinico-pathological syndrome of heparin-induced thrombocytopenia (HIT) can present as isolated thrombocytopenia or in association with a thrombotic event.

Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. The webinar presentation will discuss the pathogenesis, incidence, clinical and laboratory ...

It has been stated that the incidence of heparin-induced thrombocytopenia is lower in patients treated with low-molecular-weight heparin than in those treated with formulations of unfractionated ...

The HIT market is projected to be around USD 128 million in 2023 across the 7MM, with the US holding the largest share of diagnosed cases at 51%. HIT, a severe immune reaction following heparin ...

Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction with significant thromboembolic risk. Though there are models for use of nonheparin anticoagulants, heparin remains the preferred ...

Heparin-induced thrombocytopenia (HIT) is a clinically significant immune-mediated adverse reaction to heparin therapy. It is typified by a reduction in circulating platelets while paradoxically ...

There is a potential risk of heparin-induced thrombocytopenia (HIT) in patients with severe COVID-19 who received therapeutic doses of anticoagulation, according to a new French series suggesting an ...